AIM ImmunoTech, Inc. (AIM)

0.526 +0.04 (+7.79%) USD  |  NYAM  |  Apr 22, 16:00
0.52 -0.01 (-1.14%) After-Hours: 20:00
More

AIM ImmunoTech Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Windtree Therapeutics, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade